Today, in honor of Pulmonary Hypertension Awareness Month, the American Lung Association, with support from Merck, launched a new campaign to educate and support people with a rare and ...

Referral to a PH expert centre, including for right heart catheterisation, confirms the diagnosis. Supportive measures include diuretic therapy for symptoms of right heart failure and fluid retention, ...

Future Cardiol. 2013;9(3):335-349. Because of the heterogeneity of PH etiology, personalized approaches will likely be needed for successful treatment. Thus, PH is an excellent target for personalized ...

In treatment-naïve patients with PAH, initial monotherapy improves exercise capacity, hemodynamics, and outcomes when compared with those noted among untreated patients. In patients who are newly ...

November is Pulmonary Hypertension Awareness Month, and the American Lung Association, with support from Merck, is raising ...

To correct high blood pressure of the pulmonary artery, which can arise from congenital defects of the heart, an artificial heart ucan cost upwards of $190,000. Heart disease accounted for about one ...

The Chronic Thromboembolic Pulmonary Hypertension (CTEPH) program at Baylor St. Luke’s Medical Center is one of a handful of specialized programs in the country offering expert multidisciplinary care ...

Cereno Scientific is seeking FDA clearance to launch a global clinical trial testing its CS1 therapy for pulmonary arterial ...

Researchers estimate that about 1% of the global population has pulmonary hypertension — a disease caused by high blood pressure in the blood vessels that deliver oxygen to the lungs. Past studies ...